Loading...
OTCM
GSAC
Market cap247kUSD
Dec 02, Last price  
0.00USD
1D
33.33%
1Q
33.33%
Jan 2017
-78.38%
Name

Gelstat Corp

Chart & Performance

D1W1MN
OTCM:GSAC chart
P/E
P/S
0.71
EPS
Div Yield, %
Shrs. gr., 5y
88.18%
Rev. gr., 5y
11.71%
Revenues
350k
+133.89%
1,150,37348,0353,05200244,850338,039233,97518,17823,01921,44615,8931,312,6750201,00007,0222,333149,527349,730
Net income
-373k
L+77.53%
-1,961,083-685,052-117,0631,462,505-1,473,109-6,222,975-5,792,011-1,817,827-1,083,466-463,060464,102-407,391-1,297,516-8,839175,000-177,838-475,243-761,185-210,111-373,000
CFO
-106k
L-38.34%
-181,069190,888-262,878-148,725-343,585-1,086,181-5,649,837-1,982,763-488,056-162,132-85,382-223,201-145,415-239,158-275,040-172,000-85,219-204,858-172,376-106,289

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.
IPO date
Apr 23, 1993
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT